Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia. (Q49025617)

17 February 2018

title

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia. (English)

1 reference

17 February 2018

author name string

Sigrid Nikol

1

1 reference

17 February 2018

Iris Baumgartner

2

1 reference

17 February 2018

Eric Van Belle

3

1 reference

17 February 2018

Curt Diehm

4

1 reference

17 February 2018

Adriana Visoná

5

1 reference

17 February 2018

Maurizio C Capogrossi

6

1 reference

17 February 2018

Nicole Ferreira-Maldent

7

1 reference

17 February 2018

Augusto Gallino

8

1 reference

17 February 2018

Michael Graham Wyatt

9

1 reference

17 February 2018

Lasantha Dinesh Wijesinghe

10

1 reference

17 February 2018

Melissa Fusari

11

1 reference

17 February 2018

Dominique Stephan

12

1 reference

17 February 2018

Joseph Emmerich

13

1 reference

17 February 2018

Giulio Pompilio

14

1 reference

17 February 2018

Frank Vermassen

15

1 reference

17 February 2018

Emmanuel Pham

16

1 reference

17 February 2018

Vincent Grek

17

1 reference

17 February 2018

Michael Coleman

18

1 reference

17 February 2018

François Meyer

19

1 reference

17 February 2018

publication date

1 May 2008

1 reference

17 February 2018

published in

Molecular Therapy

1 reference

17 February 2018

volume

16

1 reference

17 February 2018

issue

5

1 reference

17 February 2018

page(s)

972-978

1 reference

17 February 2018

Critical limb ischemia: definition and natural history.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of acidic fibroblast growth factor

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Adenovirus-mediated acidic fibroblast growth factor gene transfer induces angiogenesis in the nonischemic rabbit heart

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA.

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

pCOR: a new design of plasmid vectors for nonviral gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Last observation carry-forward and last observation analysis

1 reference

https://api.crossref.org/works/10.1038%2FMT.2008.33

7 January 2021

Identifiers

DOI

10.1038/MT.2008.33

1 reference

17 February 2018

1 reference

17 February 2018